Back to Browse Journals » International Journal of Nanomedicine » Volume 1 » Issue 4

Megestrol acetate in cachexia and anorexia

Authors Shing-Shing Yeh, Michael W Schuster

Published Date February 2006 Volume 2006:1(4) Pages 411—416


Published 23 February 2006

Shing-Shing Yeh1, Michael W Schuster2

1Northport vAMC, Geriatric division, Northport, NY 11768; 2Weill Medical College of Cornell University and the New York Presbyterian Hospital, New York, NY 10021, USA

Abstract: The aim is to review major clinical trials that have used megestrol acetate (MA) in the treatment of cachexia across several disease states. A review of general usage and potential side-effects are discussed. A theory that the newly approved nanocrystal formation of MA can better deliver this potent medication for treatment will also be reviewed.

Keywords: megestrol acetate, nanocrystalline particles, cachexia

Download Article [PDF] 

Readers of this article also read:

Self-reported chronic pain is associated with physical performance in older people leaving aged care rehabilitation

Pereira LS, Sherrington C, Ferreira ML, Tiedemann A, Ferreira PH, Blyth FM, Close JC, Taylor M, Lord SR

Clinical Interventions in Aging 2014, 9:259-265

Published Date: 5 February 2014

Sigma-1 receptor concentration in plasma of patients with late-life depression: a preliminary study

Shimizu H, Takebayashi M, Tani M, Tanaka H, Yamagata B, Kurosawa K, Yamada H, Hachisu M, Hisaoka-Nakashima K, Okada-Tsuchioka M, Mimura M, Iwanami A

Neuropsychiatric Disease and Treatment 2013, 9:1867-1872

Published Date: 6 December 2013

Effectiveness of preventive home visits in reducing the risk of falls in old age: a randomized controlled trial

Luck T, Motzek T, Luppa M, Matschinger H, Fleischer S, Sesselmann Y, Roling G, Beutner K, König HH, Behrens J, Riedel-Heller SG

Clinical Interventions in Aging 2013, 8:697-702

Published Date: 12 June 2013

Development of novel cationic chitosan- and anionic alginate–coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol

Sanna V, Roggio AM, Siliani S, Piccinini M, Marceddu S, Mariani A, Sechi M

International Journal of Nanomedicine 2012, 7:5501-5516

Published Date: 17 October 2012

Nanomed Conference 2006 ||FREE ABSTRACTS||

Abstracts of papers presented at the Nanomed Conference, 27 and 28 June 2006, Newcastle upon Tyne, UK

International Journal of Nanomedicine 2006, 1:367-371

Published Date: 7 May 2006

Spatial control over cell attachment by partial solvent entrapment of poly lysine in microfluidic channels

Nicki K Baman, Galen B Schneider, Treniece L Terry, Rebecca Zaharias, Aliasger K Salem

International Journal of Nanomedicine 2006, 1:213-217

Published Date: 25 January 2006

Mood fluctuations in Parkinson’s disease: a pilot study comparing the effects of intravenous and oral levodopa administration

Irene Hegeman Richard, Samuel Frank, Kori A LaDonna, Hongkun Wang, Michael P McDermott, Roger Kurlan

Neuropsychiatric Disease and Treatment 2005, 1:261-268

Published Date: 18 February 2005

Marked effect of milnacipran combined with olanzapine for a delusional depressive patient

Yuka Sugawara, Hisashi Higuchi, Keizo Yoshida, Tetsuo Shimizu

Neuropsychiatric Disease and Treatment 2005, 1:373-374

Published Date: 18 February 2005